| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | ― | ― | ― | ― | ― | ― | |
68 Neutral | C$6.61M | 18.48 | 7.09% | ― | 6.00% | -1.43% | |
60 Neutral | C$3.01M | 4.64 | ― | ― | 0.73% | ― | |
50 Neutral | C$2.18M | -4.05 | -67.49% | ― | 16.23% | -94.74% | |
41 Neutral | C$18.13M | -9.21 | ― | ― | 37.33% | -7.55% | |
35 Underperform | C$10.73M | -4.08 | ― | ― | ― | -716.67% |
Novra Technologies has announced a partial closing and third extension of its Convertible Loan Agreement with SNAPS Holding Company, initially set in September 2024. The agreement involves a US $9 million loan, with the first tranche of US $500,000 already received, convertible into common shares. The closing date for the remaining US $8.5 million has been extended to December 15, 2025, pending necessary approvals. Despite SNAPS’ commitment, anticipated funds have not yet been received, and Novra warns investors against undue reliance on forward-looking statements. Additionally, Novra’s directors were re-elected at the recent AGM, and a trading blackout remains in effect for insiders.